ARTICLE | Company News
UCSD, U of Manitoba, St. Boniface Hospital Albrechtsen Research Center, WinSanTor deal
January 27, 2017 9:02 PM UTC
The organizations granted WinSanTor an exclusive license to develop and commercialize small molecule antagonists of muscarinic receptor to treat peripheral neuropathy. The lead compound, WST-057, is i...